Related Articles
RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients
Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer
Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
Topoisomerase II levels and drug response in small cell lung cancer